BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 27114532)

  • 21. ATM and Chk2-dependent phosphorylation of MDMX contribute to p53 activation after DNA damage.
    Chen L; Gilkes DM; Pan Y; Lane WS; Chen J
    EMBO J; 2005 Oct; 24(19):3411-22. PubMed ID: 16163388
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Fusion Protein of the p53 Transaction Domain and the p53-Binding Domain of the Oncoprotein MdmX as an Efficient System for High-Throughput Screening of MdmX Inhibitors.
    Chen R; Zhou J; Qin L; Chen Y; Huang Y; Liu H; Su Z
    Biochemistry; 2017 Jun; 56(25):3273-3282. PubMed ID: 28581721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MdmX protects p53 from Mdm2-mediated degradation.
    Jackson MW; Berberich SJ
    Mol Cell Biol; 2000 Feb; 20(3):1001-7. PubMed ID: 10629057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MDMX inhibits the p300/CBP-mediated acetylation of p53.
    Sabbatini P; McCormick F
    DNA Cell Biol; 2002 Jul; 21(7):519-25. PubMed ID: 12162806
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MDM2 interacts with MDMX through their RING finger domains.
    Tanimura S; Ohtsuka S; Mitsui K; Shirouzu K; Yoshimura A; Ohtsubo M
    FEBS Lett; 1999 Mar; 447(1):5-9. PubMed ID: 10218570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stabilization of the MDM2 oncoprotein by interaction with the structurally related MDMX protein.
    Sharp DA; Kratowicz SA; Sank MJ; George DL
    J Biol Chem; 1999 Dec; 274(53):38189-96. PubMed ID: 10608892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDMX: from bench to bedside.
    Marine JC; Dyer MA; Jochemsen AG
    J Cell Sci; 2007 Feb; 120(Pt 3):371-8. PubMed ID: 17251377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the conformational transitions of MDM2 and MDMX: insights into key residues affecting p53 recognition.
    Carotti A; Macchiarulo A; Giacchè N; Pellicciari R
    Proteins; 2009 Nov; 77(3):524-35. PubMed ID: 19507240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
    Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
    Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ATM-mediated phosphorylations inhibit Mdmx/Mdm2 stabilization by HAUSP in favor of p53 activation.
    Meulmeester E; Pereg Y; Shiloh Y; Jochemsen AG
    Cell Cycle; 2005 Sep; 4(9):1166-70. PubMed ID: 16082221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of MDMX nuclear import and degradation by Chk2 and 14-3-3.
    LeBron C; Chen L; Gilkes DM; Chen J
    EMBO J; 2006 Mar; 25(6):1196-206. PubMed ID: 16511560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hetero-oligomerization with MdmX rescues the ubiquitin/Nedd8 ligase activity of RING finger mutants of Mdm2.
    Singh RK; Iyappan S; Scheffner M
    J Biol Chem; 2007 Apr; 282(15):10901-7. PubMed ID: 17301054
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficient p53 activation and apoptosis by simultaneous disruption of binding to MDM2 and MDMX.
    Hu B; Gilkes DM; Chen J
    Cancer Res; 2007 Sep; 67(18):8810-7. PubMed ID: 17875722
    [TBL] [Abstract][Full Text] [Related]  

  • 34.
    Song Q; Liu XQ; Rainey JK
    Biomol NMR Assign; 2022 Apr; 16(1):171-178. PubMed ID: 35359247
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
    Okamoto K; Taya Y; Nakagama H
    FEBS Lett; 2009 Sep; 583(17):2710-4. PubMed ID: 19619542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional Interrogation of the N-Terminal Lid of MDMX in p53 Binding via Native Chemical Ligation.
    Chen X; Lu W
    Chem Pharm Bull (Tokyo); 2016; 64(7):1004-8. PubMed ID: 27373663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optimal Affinity Enhancement by a Conserved Flexible Linker Controls p53 Mimicry in MdmX.
    Borcherds W; Becker A; Chen L; Chen J; Chemes LB; Daughdrill GW
    Biophys J; 2017 May; 112(10):2038-2042. PubMed ID: 28487147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a domain within MDMX-S that is responsible for its high affinity interaction with p53 and high-level expression in mammalian cells.
    Rallapalli R; Strachan G; Tuan RS; Hall DJ
    J Cell Biochem; 2003 Jun; 89(3):563-75. PubMed ID: 12761890
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AMP-activated protein kinase induces p53 by phosphorylating MDMX and inhibiting its activity.
    He G; Zhang YW; Lee JH; Zeng SX; Wang YV; Luo Z; Dong XC; Viollet B; Wahl GM; Lu H
    Mol Cell Biol; 2014 Jan; 34(2):148-57. PubMed ID: 24190973
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDM2 and MDMX can interact differently with ARF and members of the p53 family.
    Wang X; Arooz T; Siu WY; Chiu CH; Lau A; Yamashita K; Poon RY
    FEBS Lett; 2001 Feb; 490(3):202-8. PubMed ID: 11223036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.